Related Experiment Video
Updated: Jun 30, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Chronic obstructive pulmonary disease and cytokines
1Georgetown University School of Nursing & Health Studies, Washington, District of Colombia 20057, USA. angerioa@georgetown.edu
Critical Care Nursing Quarterly
|September 26, 2008
Summary
Chronic obstructive pulmonary disease (COPD) significantly impacts health. Research into cellular inflammation, including interleukins and transforming growth factor-beta, may reveal new COPD treatment strategies.
Area of Science:
- Pulmonary Medicine
- Cellular Biology
- Immunology
Background:
- Chronic obstructive pulmonary disease (COPD) is a major global health concern, contributing significantly to illness and death.
- Current understanding of COPD pathogenesis at the cellular level remains incomplete, hindering the development of advanced therapeutic interventions.
- Inflammatory processes are recognized as key drivers in the progression of COPD.
Purpose of the Study:
- To investigate the role of specific inflammatory mediators in the cellular evolution of COPD.
- To explore the significance of interleukins and transforming growth factor-beta in COPD development.
Main Methods:
- This study focuses on the molecular and cellular mechanisms underlying COPD.
- Analysis involves examining the expression and function of key inflammatory mediators.
Main Results:
- Interleukins are identified as critical players in the inflammatory cascade associated with COPD.
- Transforming growth factor-beta also demonstrates a significant role in the cellular pathology of COPD.
Conclusions:
- Understanding the cellular inflammatory pathways involving interleukins and TGF-β is crucial for advancing COPD treatment.
- Targeting these specific mediators may offer novel therapeutic avenues for managing COPD effectively.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: